These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28668178)

  • 1. Cholinergic symptoms and QTc prolongation following donepezil overdose.
    Pourmand A; Shay C; Redha W; Aalam A; Mazer-Amirshahi M
    Am J Emerg Med; 2017 Sep; 35(9):1386.e1-1386.e3. PubMed ID: 28668178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil overdose: a tenfold dosing error.
    Shepherd G; Klein-Schwartz W; Edwards R
    Ann Pharmacother; 1999; 33(7-8):812-5. PubMed ID: 10466911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil induces ventricular arrhythmias by delayed repolarisation.
    Kho J; Ioannou A; Mandal AKJ; Missouris CG
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):559-560. PubMed ID: 33230575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged altered mental status and bradycardia following pediatric donepezil ingestion.
    Garlich FM; Balakrishnan K; Shah SK; Howland MA; Fong J; Nelson LS
    Clin Toxicol (Phila); 2014 Apr; 52(4):291-4. PubMed ID: 24735001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cholinergic syndrome in a patient taking the prescribed dose of donepezil for Alzheimer's disease.
    Hanazawa T; Kamijo Y; Yoshizawa T; Fujita Y; Usui K; Haga Y
    Psychogeriatrics; 2020 Jul; 20(4):538-539. PubMed ID: 32065723
    [No Abstract]   [Full Text] [Related]  

  • 6. Donepezil overdose.
    Greene YM; Noviasky J; Tariot PN
    J Clin Psychiatry; 1999 Jan; 60(1):56-7. PubMed ID: 10074883
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symptomatic sinus bradycardia associated with donepezil].
    Calvo-Romero JM; Ramos-Salado JL
    Rev Neurol; 1999 Jun 1-15; 28(11):1070-2. PubMed ID: 10390778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of acute cholinergic adverse effects induced by donepezil overdose: a follow-up of clinical course and plasma concentration of donepezil].
    Yano H; Fukuhara Y; Wada K; Kowa H; Nakashima K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):482-6. PubMed ID: 14658400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organophosphate poisoning versus brainstem stroke.
    Beare CH; Buckley NA
    Med J Aust; 2000 Jan; 172(2):96. PubMed ID: 10738489
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil.
    Suleyman T; Tevfik P; Abdulkadir G; Ozlem S
    Emerg Med J; 2006 Aug; 23(8):641-2. PubMed ID: 16858101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.
    Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Ikeda M
    Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe worsening of parkinsonism in Lewy body dementia due to donepezil.
    Onofrj M; Thomas A
    Neurology; 2003 Nov; 61(10):1452. PubMed ID: 14638981
    [No Abstract]   [Full Text] [Related]  

  • 13. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donepezil-related toxic hepatitis.
    Dierckx RI; Vandewoude MF
    Acta Clin Belg; 2008; 63(5):339-42. PubMed ID: 19186568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease.
    Igeta H; Suzuki Y; Motegi T; Sasaki A; Yokoyama Y; Someya T
    Gen Hosp Psychiatry; 2013; 35(6):680.e9-10. PubMed ID: 23731891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil use in Alzheimer disease.
    Barner EL; Gray SL
    Ann Pharmacother; 1998 Jan; 32(1):70-7. PubMed ID: 9475825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Alzheimers Dis; 2014; 42 Suppl 3():S281-8. PubMed ID: 24898643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease.
    Prvulovic D; Schneider B
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):1039-50. PubMed ID: 24785550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.